Last reviewed · How we verify
NCT06987838
Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea
NA trial testing Pharmacological treatment in Primary Dysmenorrhea in 50 participants. Not yet recruiting.
25 August 2025
Quick facts
| Lead sponsor | Benha National University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 25 May 2025 |
| Primary completion | 25 August 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Pharmacological treatment — full drug profile →
- Virtual reality
Conditions studied
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Benha National University
Who can join
Adults 17 to 21, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06987838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pharmacological treatment
Trials testing the same drug.
- NCT06630208 — Effectiveness of Myofascial Release in Patients With Chronic Post Sternotomy Pain Syndrome · NA · not yet recruiting
- NCT06652776 — The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease · enrolling by invitation
- NCT04343391 — Brief Psychotherapies for Emotional Disorders in Primary and Secondary Care · NA · completed
Other recruiting trials for Primary Dysmenorrhea
Currently open trials in the same condition.
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
- NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
- NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06987838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Benha National University
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06987838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing